Luc Te Marvelde

Luc Te Marvelde

Auto-generated profile, based on publicly available information

Luc Te Marvelde

Victorian Cancer Registry Cancer Council Victoria Melbourne Victoria Australia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2021 in Medical Journal of Australia
Verified
Journal Article
Closed access
PDF file
LMLuc Te Marvelde
Luc Te Marvelde
RWRory Wolfe
Rory Wolfe
Grant McarthurGrant Mcarthur
Grant Mcarthur
LBLouis A Blake
Louis A Blake
SESue Evans
Sue Evans
Click on the article title to read more.

18 September 2019 in Australian and New Zealand Journal of Public Health
Verified
Journal Article
Open access
PDF file
LMLuc Te Marvelde
Luc Te Marvelde
AWAnn Whitfield
Ann Whitfield
JSJennie Shepheard
Jennie Shepheard
CRCarla Read
Carla Read
RMRoger L. Milne
Roger L. Milne
KWKathryn Whitfield
Kathryn Whitfield
Objective: To determine the clinical characteristics, outcomes and longitudinal trends of sepsis occurring in cancer patients. Method: Retrospective study using statewide Victorian Cancer Registry data linked to various administrative datasets. Results: Among 215,763 incident cancer patients, incidence of sepsis within one year of cancer diagnosis was estimated at 6.4%. The incidence of sepsis was higher in men, younger patients, patients diagnosed with haematological malignancies and those with de novo metastatic disease. Of the 13,316 patients with a first admission with sepsis, 55% had one or more organ failures, 29% required care within an intensive care unit and 13% required mechanical ventilation. Treatments associated with the highest sepsis incidence were stem cell/bone marrow transplant (33%), major surgery (4.4%), chemotherapy (1.1%) and radical radiotherapy (0.6%). The incidence of sepsis with organ failure increased between 2008 and 2015, while 90‐day mortality decreased. Conclusions: Sepsis in patients with cancer has high mortality and occurs most frequently in the first year after cancer diagnosis. Implications for public health: The number of cancer patients diagnosed with sepsis is expected to increase, causing a substantial burden on patients and the healthcare system.

30 September 2020 in Medical Journal of Australia
Verified
Journal Article
Open access
PDF file
LMLuc Te Marvelde
Luc Te Marvelde
RMRoger L Milne
Roger L Milne
CHColin J Hornby
Colin J Hornby
ACAdam B Chapman
Adam B Chapman
GGGraham G Giles
Graham G Giles
IHIan E Haines
Ian E Haines
Objective To compare treatments for localised prostate cancer for men diagnosed in private and public health services in Victoria. Design Retrospective analysis of Victorian Cancer Registry data l...

3 May 2023 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
NKNadia N. Khan
Nadia N. Khan
SESue M. Evans
Sue M. Evans
LILiane J. Ioannou
Liane J. Ioannou
CPCharles H. C. Pilgrim
Charles H. C. Pilgrim
MBMegan Blanchard
Megan Blanchard
LMLuc Te Marvelde
Luc Te Marvelde
Purpose: Despite the benefits of palliative care (PC) in pancreatic cancer, little is known about patients who access PC. This observational study examines the characteristics of patients with pancreatic cancer at their first episode of PC. Methods: First-time, specialist PC episodes captured through the Palliative Care Outcomes Collaboration (PCOC), in Victoria, Australia between 2014 and 2020, for pancreatic cancer, were identified. Multivariable logistic regression analyses examined the impact of patient- and service-level characteristics on symptom burden (measured through patient-reported outcome measures and clinician-rated scores) at first PC episode. Results: Of 2890 eligible episodes, 45% began when the patient was deteriorating and 32% ended in death. High fatigue and appetite-related distress were most common. Generally, increasing age, higher performance status and more recent year of diagnosis predicted lower symptom burden. No significant differences were noted between symptom burden of regional/remote versus major city dwellers; however, only 11% of episodes recorded the patient as a regional/remote resident. A greater proportion of first episodes for non-English-speaking patients began when the patient was unstable, deteriorating or terminal, ended in death and were more likely to be associated with high family/carer problems. Community PC setting predicted high symptom burden, with the exception of pain. Conclusion: A large proportion of first-time specialist PC episodes in pancreatic cancer begin at a deteriorating phase and end in death, suggesting late access to PC. Timely referrals to community-based specialist PC, access in regional/remote areas, as well as development of culturally diverse support systems require further investigation.

17 July 2023 in Cancer Medicine
Verified
Journal Article
Open access
GSGeoffrey W. Stuart
Geoffrey W. Stuart
JCJames Chamberlain
James Chamberlain
LMLuc Te Marvelde
Luc Te Marvelde
Background: Breast cancer survival in Australia varies according to socio‐economic status (SES) and between rural and urban places of residence. Part of this disparity may be due to differences in prognostic factors at the time of diagnosis.Methods: Women with invasive breast cancer diagnosed from 2008 until 2012 (n = 14,165) were identified from the Victorian Cancer Registry and followed up for 5 years, with death from breast cancer or other causes recorded. A prognostic score, based on stage at diagnosis, cancer grade, whether the cancer was detected via screening, reported comorbidities and age at diagnosis, was constructed for use in a mediation analysis.Results: Five‐year breast cancer mortality for women with breast cancer who were in the lowest quintile of SES (10.3%) was almost double that of those in the highest quintile (5.7%). There was a small survival advantage (1.7% on average, within each socio‐economic quintile) of living in inner‐regional areas compared with major cities. About half of the socio‐economic disparity was mediated by prognostic factors, particularly stage at diagnosis and the presence of comorbidities. The inner‐regional survival advantage was not due to differences in prognostic factors.Conclusions: Part of the socio‐economic disparity in breast cancer survival could be addressed by earlier detection in, and improved general health for, more disadvantaged women. Further research is required to identify additional causes of socio‐economic disparities as well as the observed inner‐regional survival advantage.

3 April 2015 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
PDF file
AHAlan Herschtal
Alan Herschtal
LMLuc Te Marvelde
Luc Te Marvelde
KMKerrie Mengersen
Kerrie Mengersen
FFFarshad Foroudi
Farshad Foroudi
TEThomas Eade
Thomas Eade
Tomas KronTomas Kron
Tomas Kron